KEMRI said in a statement issued in Nairobi, the capital of Kenya, that the Phase I clinical trial of TNX-801, an investigational vaccine designed to prevent mpox will take place in Kenya, focusing on ...
Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...